Quantification of an External Motion Surrogate for Quality Assurance in Lung Cancer Radiation Therapy

Table 1

Patient data, including age at treatment time, sex, entity plus stage of primary tumor and the treated tumor volume in ccm.

Patient	Age	Sex	Entity	UICC	Stage	Tumor volume [ccm]
Anonymous 102	58	f	Sarcoma	IV	cT2 cN0 cM1	12.430
Anonymous 105	56	m	CUP	IV	not available	8.467
Anonymous 108	64	m	NSCLC	IIIa	cT3 cN2 M0	5.963
Anonymous 110	63	m	Prostate-Ca	IV	pT3b pN1 cM1	9.117
Anonymous 111	75	m	Sigma-Ca	IV	T2 pM1	0.819
Anonymous 112	68	m	SCLC	IV	cT2 cN2 pM1	3.829
Anonymous 113	71	m	NSCLC	IV	cT3 cN3 cM1b	18.083
Anonymous 114	50	m	Sarcoma	IV	ypT2b pM1	55.317
Anonymous 115	50	f	NSCLC	IV	cT2 cN3 cM1	31.357
Anonymous 116	56	m	HNSCC	IVc	cT1 cN3 cM1	1.213
Anonymous 117	51	m	Rectum-Ca	IV	cT3 cN+ cM1	1.137
Anonymous 118	44	m	Melanoma	IV	pT4b M1c	17.514
Anonymous 119	33	m	NSCLC	IIIb	cT1 cN3 cM0	3.431
Anonymous 120	80	m	NSCLC	IIIb	cT4 cN2 cM0	7.205
Anonymous 121	45	m	NSCLC	IV	cT2 cN2 cM1	4.167
Anonymous 123	80	m	NSCLC	IV	cT3 cN1 cM1	0.503
Anonymous 124	38	f	Rectum-Ca	IV	cT4 cN0 cM1	21.483
Anonymous 125	78	m	NSCLC	IV	cT4 cN2 cM1	1.333
Anonymous 126	75	m	Rectum-Ca	IV	cT3 cN+ cM1	5.316
Anonymous 127	72	m	HNSCC	IVc	pT4 pN2 pM1	0.449